Product image of Vyloy (Zolbetuximab) supplied by GNH India

Vyloy

Active Ingredient:
Zolbetuximab
Origin:
EU

Vyloy (Zolbetuximab)

Vyloy (zolbetuximab) is an intravenous therapy for certain gastrointestinal cancers. This monoclonal antibody targets CLDN18.2 to support treatment plans. Designed for adult patients, it is administered in clinical settings under professional supervision.

Manufacturer / TM Owner

Astellas Pharma Europe B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyloy is used in combination with chemotherapy to treat adults with locally advanced unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. It is indicated for patients whose tumors express CLDN18.2. This targeted therapy helps support standard cancer treatment protocols by focusing on specific cancer cell markers.

Side Effects

  • As a monoclonal antibody, Vyloy works by binding to CLDN18.2 proteins on cancer cells, which may slow disease progression. Patients may experience infusion-related reactions such as nausea, vomiting, or fatigue during or after administration. These effects are typically monitored by healthcare providers.

Precautions & Warnings

  • Vyloy is administered by healthcare professionals in a controlled environment. Patients should report any signs of infusion reactions, including chills or dizziness, immediately. Pre-medication may be given to reduce reaction risks. Regular monitoring ensures safe and effective use.

Avoid Interactions

  • Vyloy is given alongside chemotherapy, and interactions with other systemic therapies are managed by oncology teams. No specific drug-drug interactions have been widely reported, but caution is advised when combining with other agents that may affect immune response. Always disclose all medications to your healthcare provider.

Frequently Asked Questions

Vyloy is used to treat adults with advanced gastric or gastroesophageal junction cancer whose tumors express CLDN18.2.

Vyloy is given as an intravenous infusion in a clinical setting under medical supervision.

Common effects may include nausea, vomiting, and fatigue, often monitored during treatment.

Vyloy is used with chemotherapy; all medications should be disclosed to your healthcare provider before starting treatment.

No, Vyloy is administered in a healthcare facility due to the need for professional monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Zolbetuximab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT